期刊文献+

CD_(105)和HIF-1α在侵袭性垂体瘤中的表达 被引量:3

Expression of CD_(105) and hypoxia inducible factor-1α (HIF-1α) in invasive pituitary tumors
下载PDF
导出
摘要 目的研究CD105和缺氧诱导因子-la(HIF-1α)在侵袭性垂体瘤中的表达水平,并探讨CD105标记的MVD密度及HIF-1α在侵袭性垂体瘤中的生物学意义和作用。方法收集2005-2010年的侵袭性垂体瘤手术标本25例,非侵袭性垂体瘤15例,用免疫组化方法检测CD105及HIF-1α的表达,并对CD105标记的MVD进行计数,结果进行对照分析。结果所有垂体瘤标本均有CD105表达,40例标本CD105-MVD均值为(16.2±6.1),侵袭性组为(21.8±2.8),非侵袭性组为(10.6±2.2);HIF-1α表达情况:侵袭性组为14例阳性,11例阴性;非侵袭性组为3例阳性,12例阴性。经统计学分析侵袭性与非侵袭性垂体瘤中CD105和HIF-1α的表达存在显著差异,有统计学意义(P<0.05)。结论侵袭性垂体瘤中CD105和HIF-1α的表达明显增高,CD105和HIF-1α参与侵袭性垂体瘤的发生、发展。CD105和HIF-1α可以作为预测垂体瘤侵袭性的免疫检测指标。 Objective To study the expression of CD105 and hypoxia-inducible factor 1a(HIF-1α) in the invasive pituitary tumor and to explore the biological significance and role of microvessel density(MVD) marked by CD105 and that of HIF-1α in the invasive pituitary tumor.Methods Twenty five surgical specimens from cases with invasive pituitary tumors and fifteen surgical specimens from cases of non-invasive pituitary tumors were collected from 2005 to 2010.Immunohistochemical technique was used to detect the expression of CD105 and HIF-1α,and the MVD marked by CD105 was counted.Comparison analysis was performed on the data obtained.Results All the specimens were found to express CD105.The mean CD105-MVD value of the 40 cases was(16.2±6.1),which was(21.8±2.8) in the invasive group and(10.6±2.2) in the non-invasive group.HIF-1α expression analysis showed 14 cases(+) and 11 cases(-) in the invasive group,and 3 cases(+) and 12 cases(-) in the non-invasive group.Statistical analysis revealed the differences of the expression of CD105 and HIF-1α between the two groups was statistically significant(P〈0.05).Conclusion The CD105 and HIF-1α expression in the invasive pituitary tumor is significantly higher than that in the non-invasive group,which indicates that CD105 and HIF-1α are involved in the occurrence and development of invasive pituitary tumor.CD105 and HIF-1α could serve as immunological detection indicators for predicting the invasiveness of pituitary tumor.
出处 《海南医学》 CAS 2011年第16期4-8,共5页 Hainan Medical Journal
关键词 垂体瘤 侵袭性 CD105 HIF-1Α Pituitary tumor Invasiveness CD105 Hypoxia inducible factor-1α(HIF-1α)
  • 相关文献

参考文献13

  • 1Thapar K, Laws ER Jr. Growth homone secreting pituitary tumors: operative management [A]. In: Krisht AF, Tindall GT, ed. Pituitary disorders comprehensive management [M]. Baltimore, Maryland, USA: Lippincott Williams & Wilkins, 1999: 43-258.
  • 2黄垂学,刘运生,侯永宏,刘志雄,傅春燕,黄海萍.半乳糖凝集素-3的表达与垂体腺瘤侵袭性关系[J].海南医学,2007,18(5):17-19. 被引量:2
  • 3郑安锡,肖文峰,霍钢.侵袭性垂体腺瘤血管生成研究进展[J].现代医学,2007,35(4):332-335. 被引量:3
  • 4Perez-Gomez E. Eleno N, Lopez-Novoa JM, et al. Characterization of murine S-er,~oglin isoform and its effects on tumor development [J]. Oncogene, 2005, 24(27): 4450-4461.
  • 5Li C, Guo B, Wilson PB, et al. Plasma levels of soluble CD105 corre- late with metastasis in patients with breast cancer [J]. Int J Cancer, 2000, 89(2): 122-126.
  • 6Miller DW, Graulich W, Karges B, et al. Elevated expression of CD105, a component of the TGF beta receptor complex, correlates with proliferation of tumor endothelial cell [J]. Int J Cancer, 1999, 81(4): 568-572.
  • 7Semenza GL. HIF- 1 Mediator of physiological and pathophysio log- ical response to hypoxia [J]. Appl Physiol, 2000, 2(88): 1474-1480.
  • 8宋武战,池君,汪静.缺氧诱导因子HIF-lα与恶性肿瘤[J].西南军医,2008,10(1):104-106. 被引量:7
  • 9Semenza G. Signal transduction to hypoxia-inducible factor 1 [J]. Biochem Pharmacol, 2002, 64(5-6): 993-998.
  • 10Kaur B, Khwaja FW, Severson EA, et al. Hypoxia and the hypox- ia--inducible-factor pathway in glioma growth and angiogenesis [J]. Neuro--oncol, 2005, 7(2): 1 34-153.

二级参考文献57

  • 1戴如飞,刘宁,朱风仪,赵春生,周明卫.血管内皮生长因子和P53及细胞增殖核抗原蛋白表达与垂体腺瘤复发的关系[J].中华检验医学杂志,2004,27(7):431-433. 被引量:2
  • 2Yan-guoKong Zu-yuanRen Chang-baoSu Ren-zhiWang Wen-bingMa WeiLian.ELEVATED SOLUBLE EPIDERMAL GROWTH FACTOR RECEPTOR LEVEL IN PITUITARY ADENOMA AND CARCINOMA[J].Chinese Medical Sciences Journal,2004,19(3):199-202. 被引量:4
  • 3王化丽,张淑兰,鲁艳明,姜继勇,朱晓钰.肝细胞生长因子对卵巢癌细胞侵袭的促进作用及信号转导途径[J].癌症,2006,25(5):570-575. 被引量:4
  • 4任祖渊.侵袭性垂体瘤的研究现状及展望[J].中华神经外科杂志,2000,16:112-115.
  • 5Fraipont F,Nicholson AC,Feige JJ,et al.Thrombospondins and tumor angiogenesis.Trends Mol Med,2001,7:401-407.
  • 6Ikezu T,Okamoto T,Yonezawa K,et al.Analysis of thermal injuryinduced insulin resistance in rodents.Biochem J,1997,272:25289-25295.
  • 7Hanahan D,Folkman J.Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.Cell,1996,86:353-364.
  • 8Renner U,Lohrer P,Schaaf L,et al.Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells.Endocrinology,2002,143:3759-3765.
  • 9Horiguchi H,Jin Long,Ruebel H,et al.Regulation of VEGF-A,VEGFR-I,thrombospondin-1,-2,and -3 expressions in a human pituitary cell line (HP75) by tGF[beta] 1,bFGF,and EGF.Endocrine,2004,24:141-146.
  • 10Nakagawa T,Lan HY,Glushakova O,et al.Role of ERKi/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta 1 in rat proximal tubular cells and mouse fibroblasts.J Am Soc Nephrol,2005,16:899-904.

共引文献14

同被引文献26

  • 1朱在卿,许贵刚,刘洋,郭艳丽.PTTG在垂体瘤组织中的表达及意义[J].山东医药,2008,48(5):94-95. 被引量:4
  • 2胡静芳,苏青,蔡瑜.垂体瘤转化基因在垂体大腺瘤中的表达及其与肿瘤侵袭性的关系[J].上海交通大学学报(医学版),2006,26(2):193-195. 被引量:2
  • 3郑安锡,肖文峰,霍钢.侵袭性垂体腺瘤血管生成研究进展[J].现代医学,2007,35(4):332-335. 被引量:3
  • 4李爱军,王道奎,王永和,曹培成,张振兴,王玉亭.PTTG、MMPs、VEGF在侵袭性垂体腺瘤中的表达及其意义[J].中国临床神经外科杂志,2007,12(7):418-421. 被引量:6
  • 5Al-Shraim M ,Asa SL. The 2004 World Health Organization classific- ation of pituitary tumors: what is new [ J ]. Acta Neuropathologica, 2006,111:1.
  • 6Scheithauer BW, Gaffey TA, Lloyd RV, et al. Pathobiology of pituit- ary adenomas and carcinomasEJ. Neurosurgery,2006,59:341.
  • 7Cornelius A, Cortet-Rudelli C, Assaker R, et al. Endothelial expr- ession of endocan is strongly associated with tumor progression in pituitary adenoma [ J 1. Brain Pathol, 2012,2 : 1750.
  • 8De Witte O, Carlot S, Devuyst E, et al. Minimally invasive endo- scopic unilateral transsphenoidal surgery for pituitary adenomas [ J ]. B-ENT,2011,7 :27.
  • 9Wu ZB, Yu C J, Su PZ, et al. Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up [ J ]. Journal of Neurosurgery,2006,104:54.
  • 10Molitch ME, Cowen L, Stadiem R, et al. Tumors invading the cavernous sinus that cause internal carotid artery compression are rarely pituitary adenomas[ J]. Pituitary,2012, 2:4.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部